Cost-effectiveness of a text message programme for the prevention of recurrent cardiovascular events

被引:43
|
作者
Burn, Edward [1 ]
Nghiem, Son [1 ]
Jan, Stephen [2 ]
Redfern, Julie [2 ]
Rodgers, Anthony [2 ]
Thiagalingam, Aravinda [3 ,4 ]
Graves, Nicholas [1 ]
Chow, Clara K. [2 ,3 ,4 ]
机构
[1] Queensland Univ Technol, Brisbane, Qld, Australia
[2] Univ Sydney, George Inst Global Hlth, Sydney Med Sch, Sydney, NSW, Australia
[3] Westmead Hosp, Dept Cardiol, Sydney, NSW, Australia
[4] Univ Sydney, Westmead Clin Sch, Sydney, NSW, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
CORONARY-HEART-DISEASE; RISK-FACTOR; LIFE-STYLE; SMOKING; HEALTH; MODEL; INTERVENTIONS; INDIVIDUALS; UNCERTAINTY; STROKE;
D O I
10.1136/heartjnl-2016-310195
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To estimate the cost-effectiveness of Tobacco, Exercise and Diet Messages (TEXT ME), a text message-based intervention that provides advice, motivation, information and support to improve health-related behaviours. Methods A lifetime Markov model was used to estimate major vascular events (myocardial infarctions and strokes) avoided, quality-adjusted life years (QALYs) gained, costs to the health system and the incremental cost per QALY gained. The model was informed by data from a randomised controlled trial of TEXT ME, with evidence from systematic reviews and meta-analyses used to estimate the effects of changes in risk factors on the risk of major vascular events. Expected costs and health outcomes were estimated with uncertainty surrounding these characterised using probabilistic sensitivity analysis and a number of scenario analyses. Results For a target population of 50 000 patients with documented coronary heart disease, the intervention is expected to lead to 563 fewer myocardial infarctions, 361 fewer strokes and 1143 additional QALYs. TEXT ME is expected to lead to an overall saving of $ 10.56 million for the health system over the patients' lifetimes. The intervention can therefore be considered cost-saving and health-improving. Neither parameter nor structural uncertainty had a significant impact on the conclusion that TEXT ME is cost-effective. Conclusions The provision of TEXT ME is predicted to lead to better health outcomes and an overall saving in costs for the health system.
引用
收藏
页码:923 / U57
页数:8
相关论文
共 50 条
  • [1] Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events
    Sehested, Thomas S. G.
    Bjerre, Jenny
    Ku, Seul
    Chang, Andrew
    Jahansouz, Alison
    Owens, Douglas K.
    Hlatky, Mark A.
    Goldhaber-Fiebert, Jeremy D.
    JAMA CARDIOLOGY, 2019, 4 (02) : 128 - 135
  • [2] Cost-Effectiveness of Colchicine for Recurrent Cardiovascular Events
    Boczar, Kevin E.
    Beanlands, Rob
    Wells, George
    Coyle, Doug
    CJC OPEN, 2023, 5 (05) : 348 - 356
  • [3] Cost-effectiveness of canakinumab to prevent recurrent cardiovascular events
    Sehested, T. S. G.
    Bjerre, J.
    Chang, A.
    Ku, S.
    Jahansouz, A.
    Owens, D. K.
    Hlatky, M. A.
    Goldhaber-Fiebert, J. D.
    EUROPEAN HEART JOURNAL, 2018, 39 : 503 - 504
  • [4] Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
    Djatche L.M.
    Varga S.
    Lieberthal R.D.
    PharmacoEconomics - Open, 2018, 2 (4) : 371 - 380
  • [5] Cost-Effectiveness of Canakinumab From a Canadian Perspective for Recurrent Cardiovascular Events
    Boczar, Kevin E.
    Beanlands, Rob
    Wells, George
    Coyle, Doug
    CJC OPEN, 2022, 4 (05) : 441 - 448
  • [6] COST-EFFECTIVENESS ANALYSIS OF THE USE OF STATINS IN PREVENTION OF CARDIOVASCULAR EVENTS IN COLOMBIA
    Mould, J.
    Ordonez, J.
    Gutierrez-Ardila, M., V
    Vargas Zea, N.
    VALUE IN HEALTH, 2013, 16 (07) : A666 - A666
  • [7] COST-EFFECTIVENESS OF ASPIRIN FOR PRIMARY PREVENTION OF CARDIOVASCULAR EVENTS IN CHINESE PATIENTS WITH DIABETES
    Jiang, M.
    Li, P.
    Zheng, X.
    Deng, J.
    Zhao, M.
    Fang, Y.
    VALUE IN HEALTH, 2019, 22 : S129 - S129
  • [8] Cost-effectiveness of cardiovascular prevention programs in Spain
    Plans-Rubio, P
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1998, 14 (02) : 320 - 330
  • [9] Cost-effectiveness of atorvastatin in the prevention of cardiovascular events in diabetic patients: A French adaptation of CARDS
    Lafuma, Antoine
    Colin, Xavier
    Solesse, Anne
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2008, 101 (05) : 327 - 332
  • [10] LONG-TERM COST-EFFECTIVENESS OF ADHERENCE TO ASPIRIN FOR SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS
    Djatche, L.
    Varga, S.
    Liebertal, R.
    VALUE IN HEALTH, 2017, 20 (05) : A9 - A9